Effects on tumor metabolism could be linked to inhibition of AKT and HIF-1α phosphorylation/expression by RICTOR blockade that we observed; since both factors are key players in metabolic reprogramming (reviewed by [47]). Here, RICTOR is linked to neoplasm.